US Stock MarketDetailed Quotes

PGNY Progyny

Watchlist
  • 14.340
  • +0.150+1.06%
Close Dec 20 16:00 ET
  • 14.330
  • -0.010-0.07%
Post 20:01 ET
1.22BMarket Cap23.90P/E (TTM)

About Progyny Company

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Company Profile

SymbolPGNY
Company NameProgyny
Listing DateOct 25, 2019
Issue Price13.00
Founded2008
CEOMr. Peter Anevski
MarketNASDAQ
Employees566
Fiscal Year Ends12-31
Address1359 Broadway
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10018
Phone1-212-888-3124

Company Executives

  • Name
  • Position
  • Salary
  • Peter Anevski
  • Director and Chief Executive Officer
  • 1.09M
  • Mark Livingston
  • Chief Financial Officer and Principal Accounting Officer
  • 1.40M
  • Allison Swartz
  • Executive Vice President, General Counsel and Secretary
  • 546.22K
  • Michael Sturmer
  • President
  • 1.49M
  • David J. Schlanger
  • Executive Chairman of the Board
  • 513.57K
  • Jeffrey Park
  • Independent Director
  • 606.88K
  • Kevin K. Gordon
  • Independent Director
  • 518.30K
  • Dr. Beth C. Seidenberg,M.D.
  • Lead Independent Director
  • 653.39K
  • Roger C. Holstein
  • Independent Director
  • 518.30K
  • Lloyd H. Dean
  • Independent Director
  • 518.30K
  • Dr. Norman C. Payson,M.D.
  • Independent Director
  • 567.30K
  • Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
  • Independent Director
  • 583.35K
  • Cheryl Scott
  • Independent Director
  • 518.30K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.